STOCK TITAN

Broadwood boosts STAAR Surgical (STAA) stake in Form 4 filing report

Filing Impact
(Very High)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Broadwood Partners, L.P., a 10% owner of STAAR Surgical, reported buying 27,485 shares of common stock on January 9, 2026 at a weighted average price of $22.0534 per share, bringing its directly owned stake to 15,453,629 shares.

These shares are held by Broadwood Partners and may be deemed indirectly beneficially owned by Broadwood Capital, Inc. and its president, Neal C. Bradsher, who also directly owns 25,900 shares of STAAR Surgical common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BROADWOOD PARTNERS, L.P.

(Last) (First) (Middle)
C/O BROADWOOD CAPITAL INC.
156 WEST 56TH STREET, 3RD FLOOR

(Street)
NEW YORK NY 10019

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
STAAR SURGICAL CO [ STAA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
01/09/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/09/2026 P 27,485 A $22.0534(2) 15,453,629 D(1)
Common Stock 01/09/2026 P 0 A $0 15,453,629 I Footnote(1)
Common Stock 25,900 D(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
BROADWOOD PARTNERS, L.P.

(Last) (First) (Middle)
C/O BROADWOOD CAPITAL INC.
156 WEST 56TH STREET, 3RD FLOOR

(Street)
NEW YORK NY 10019

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
BROADWOOD CAPITAL INC

(Last) (First) (Middle)
156 WEST 56TH STREET
3RD FLOOR

(Street)
NEW YORK NY 10019

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Bradsher Neal C

(Last) (First) (Middle)
C/O BROADWOOD CAPITAL, INC.
156 WEST 56TH STREET, 3RD FLOOR

(Street)
NEW YORK NY 10019

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed to be indirectly beneficially owned by: (i) Broadwood Capital, Inc. ("Broadwood Capital") as General Partner of Broadwood Partners; and (ii) Neal C. Bradsher as President of Broadwood Capital. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
2. This constitutes the weighted average purchase price. The prices range from $21.965 to $22.09. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
3. These securities are directly owned by Neal C. Bradsher.
Broadwood Partners, L.P., By: Broadwood Capital, Inc., By: /s/ Neal C. Bradsher, President 01/13/2026
Broadwood Capital, Inc., By: /s/ Neal C. Bradsher, President 01/13/2026
Neal C. Bradsher, /s/ Neal C. Bradsher 01/13/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did STAA report in this Form 4?

The filing reports that Broadwood Partners, L.P. bought 27,485 shares of STAAR Surgical common stock on January 9, 2026 at a weighted average price of $22.0534 per share.

Who is the primary owner of the STAAR Surgical (STAA) shares in this filing?

The reported securities are directly owned by Broadwood Partners, L.P., which is identified as a 10% owner of STAAR Surgical.

How many STAAR Surgical shares does Broadwood Partners hold after the transaction?

After the reported purchase, Broadwood Partners, L.P. beneficially owns 15,453,629 shares of STAAR Surgical common stock.

What role do Broadwood Capital, Inc. and Neal C. Bradsher play in this STAA Form 4?

Broadwood Capital, Inc. is the general partner of Broadwood Partners, and Neal C. Bradsher is president of Broadwood Capital. The filing states they may be deemed to indirectly beneficially own the Broadwood Partners shares, subject to their pecuniary interest.

Does Neal C. Bradsher personally own STAAR Surgical (STAA) shares?

Yes. The filing notes that 25,900 shares of STAAR Surgical common stock are directly owned by Neal C. Bradsher.

What does the weighted average price in the STAA insider purchase mean?

The filing explains that the $22.0534 figure is a weighted average purchase price, with individual trade prices ranging from $21.965 to $22.09.

Do the reporting persons admit full beneficial ownership of all STAA shares reported?

No. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest, and the filing states it is not an admission of beneficial ownership for legal purposes.

Staar Surg

NASDAQ:STAA

STAA Rankings

STAA Latest News

STAA Latest SEC Filings

STAA Stock Data

1.02B
49.48M
0.56%
111.03%
8.06%
Medical Instruments & Supplies
Ophthalmic Goods
Link
United States
MONROVIA